You searched for "innovation"
College of Optometrists calls for vital community minor and urgent eyecare services to be universally commissioned in England
Lack of funding threatens commissioning of urgent care eye services in England. The College of Optometrists calls for vital community minor and urgent eye care services to be universally commissioned in England. As demand for eye care in England continues...Global health and conflict: the unseen consequences
Global eye health inequalities stem from poor access to affordable care, causing preventative vision impairment and blindness. In 2020, a study showed that 510 million people, the majority being in low-income and middle-income countries, had uncorrected near vision impairment simply...A connected workplace - Part 2
In Part 1 of this topic (bit.ly/ENconnected) the need for a mature ophthalmic imaging network was described. Here, I provide a scoring scheme that can be used to articulate the maturity of existing devices. As with any scoring system, the...Open source and tele-manufacturing for ophthalmology
Open source or crowd-sourcing and crowd-collaboration are concepts almost always associated with software and public online projects such as Wiki project. Never had I imagined that my team would apply the same principle in ophthalmology. Just less than a month...Corneal dystrophies simplified
Based on biomicroscopic and histopathologic features, corneal dystrophies can be broadly classified into epithelial, Bowman’s layer / anterior stromal, stromal, and endothelial dystrophies. Corneal dystrophies are a group of inherited, bilateral, gradually progressing, non- inflammatory conditions caused by accumulation of...
Intravitreal Ziv-Aflibercept: safety analysis
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Bleomycin for conjunctival lymphangioma
This is a retrospective review of 16 eyes which underwent intralesional / sub-conjunctival injections of bleomycin sclerotherapy for conjunctival lymphatic malformations (lymphangiomas). The mean age was 18 (range three to 59 years). Four of the lesions were microcystic and 12...
